Characterisation of the Novel HLA‐DRB1*12:02:14 and HLA‐DRB1*12:02:15 Alleles by Next‐Generation Sequencing
HLA · 2026
DOI: 10.1111/tan.71039 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2026. Verfasst von Qi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: HLA-DRB1 Chains, Alleles, Exons, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 4 Literaturangaben. Gefördert von: the Medical and Health Science Program of Zhejiang Province.
Abstract (Originalsprache)
Compared with HLA‐DRB1*12:02:01:01 , the alleles HLA‐DRB1*12:02:14 and HLA‐DRB1*12:02:15 each show one nucleotide substitution, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Qi Li, Wenwen Pi, Yizhen He, Wei Zhang, Faming Zhu
Förderung
- the Medical and Health Science Program of Zhejiang Province
Zitieren
APA
Li, Q., Pi, W., He, Y., Zhang, W., & Zhu, F. (2026). Characterisation of the Novel HLA‐DRB1*12:02:14 and HLA‐DRB1*12:02:15 Alleles by Next‐Generation Sequencing. HLA. https://doi.org/10.1111/tan.71039
Vancouver
Li Q, Pi W, He Y, Zhang W, Zhu F. Characterisation of the Novel HLA‐DRB1*12:02:14 and HLA‐DRB1*12:02:15 Alleles by Next‐Generation Sequencing. HLA. 2026. doi:10.1111/tan.71039
BibTeX
@article{Li2026,
author = {Li, Qi and Pi, Wenwen and He, Yizhen and Zhang, Wei and Zhu, Faming},
title = {Characterisation of the Novel HLA‐DRB1*12:02:14 and HLA‐DRB1*12:02:15 Alleles by Next‐Generation Sequencing},
journal = {HLA},
year = {2026},
doi = {10.1111/tan.71039}
}
EUVIMED